HomeEXECUTIVESAxis Research & Technologies Appoints Dr. Mark G. Freeman as Chief Medical...

Axis Research & Technologies Appoints Dr. Mark G. Freeman as Chief Medical Advisor

Axis Research & Technologies, a premier bioskills training and cadaver lab supporting medical device research and training, is proud to introduce Dr. Mark G. Freeman as the company’s Chief Medical Advisor. As a board-certified orthopedic surgeon and practicing physician with Erlanger Health System, Dr. Freeman brings a unique perspective, expert clinical guidance, and surgical expertise to the revolutionary medical education labs.

Dr. Freeman has built a strong reputation for excellence with his ability to manage complex conditions including primary and revision surgeries, fractures, and musculoskeletal infections. With a biomedical engineering degree in addition to his medical education, Dr. Freeman serves as a research abstract reviewer for the American Association of Hip and Knee Surgeons, has clinical and lab research interests, and collaborates with the biomedical device and technology industry.

Well-respected across the United States for its work in supporting research, development and medical education, Axis has tapped Dr. Freeman to provide clinical input and strategic advice for enhancing labs or events from the perspective of a practicing surgeon. Additionally, Axis  serves the didactic and cadaveric training needs of medical device companies. Dr. Freeman’s interest in supporting visiting surgeons are a natural outgrowth of his own commitment to remaining a lifelong learner and encouraging the same in others.

“Axis is very fortunate to be working with Dr. Freeman,” said Nick Moran, CEO of Axis. “His status in the community and the market, his credibility as a practicing physician and his understanding of the needs of our medical device and surgical clients give us an unparalleled view into providing a full-service experience for every company or team that enters one of our bioskills labs.”

Dr. Freeman also serves as a liaison between Axis and universities, healthcare systems, academic facilities and surgery centers that will benefit from the capabilities, technologies and global, HIPAA-compliant training platform offered at all elite Axis facilities. Axis’ labs and event spaces are flexible and welcoming, supporting a wide range of specialties and disciplines.

“As a surgeon who continues to take advantage of every opportunity to learn, I’m deeply invested in helping Axis continually evolve its facilities to meet the changing needs of clients,” said Dr. Freeman. “As Chief Medical Advisor for Axis, I am proud to assist healthcare clients by offering them insights into how they can best optimize their labs and training experiences at Axis facilities.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


"We are excited to welcome Jeff Anderson to Nutjobs as our new CEO. His broad experience and tactical leadership will be instrumental in executing against our vision to provide innovative, sustainable solutions to our customers," said Paul Kephart, Co-Founder, Chief Technology Officer and Chairperson of the Nutjobs Board.
Potrero Medical believes that this voluntary reorganization will bolster its finances and facilitate its ongoing focus on elevating patient care.
Dr John Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.
“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO.
Broken String Biosciences reports Gavin Burns will be responsible for building and optimizing the companys teams, processes, and systems.

By using this website you agree to accept Medical Device News Magazine Privacy Policy